Vitagene, Inc., a smart wellness platform, empowers individuals to live happier and healthier lives by creating personalized lifestyle plans tailored to their specific goals and health profiles. Webinars & Online Training, AmpliSeq Bioinformatics Applications, Illumina Professional Research on Cannabis Industry, Initial Public Offerings (IPO), and Alternative Investments including Options, Leveraged ETFs, Penny Stocks, and other alternative investments strategies. GAAP earnings per share attributable to Illumina … Table Abbott Profiles. Terms and Conditions | It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. Table Roche Profiles. All … She earned a doctorate in Bioinformatics from University of California, San Francisco under the mentorship of Bioinformatics Department Director, Patricia Babbitt. Courtney studied transgenic mice and patient samples to identify genes involved in autism and computationally investigated alternative splicing, HPV detection, and microRNA diversity. EpiBiome, Inc. (assets acquired by Locus Biosciences Inc. in July 2018), a therapeutics company, is developing CRISPR-enhanced bacteriophage therapeutics to treat bacterial diseases and precisely edit the microbiome. Center of Individualized Diagnostic (CID), the first Illumina Accelerator Fellow is working to bringing cancer genomics diagnostics to Saudi Arabia. 66 Yeoidaero Yeoungdeungpo-gu December 1, 2020 | Twist Bioscience Corporation, Illumina, and Western Digital announced an alliance last month with Microsoft to advance the field of DNA data … Prior to joining Illumina, he has worked in the NHS to deliver sustainable transformation programs and spent several years working in the pharma industry across early research & development, global informatics, strategic finance planning, strategy for the CFO/CIO office and leading the UK pricing and innovation stream. Jay led Illumina as CEO from 1999 until 2016 and now serves as Executive Chairman of the Board of Directors. Boost Biomes, Inc., a microbial products company, is developing beneficial microbial treatments to increase crop yield, extend food shelf-life, and increase produce distribution range. for Rare Pediatric Diseases, Rare Accelerator Startup Funding, Support 02-740-5300 (tel) In the European Union, Mya has experience with working with Notified Bodies and Competent Authorities on List A, List B and self-certified products. As Senior Vice President and Chief Technology Officer, he is responsible for leading Illumina’s research and technology development functions and the innovation engine for next-generation sequencing platforms and applications, accelerating technology breakthroughs and translation to the clinic. Failures, NIPT At Illumina, we believe we can make a difference through STEM education, community outreach, and commitment to oncology and rare disease initiatives. Responsibilities … Mantra Bio, Inc., a therapeutics company, is harnessing exosomes for highly targeted in vivo delivery of novel drugs to treat intractable cancers and neurodegenerative disease. 14F KTB Building With the passion and commitment of our employees in 2019, we have been able to grow our impact around the world. Whole-Genome Sequencing, Microbiome Twist Bioscience Corporation (NASDAQ: TWST), Illumina, Inc. (NASDAQ: ILMN) and Western Digital (NASDAQ: WDC) today announced the formation of an alliance with Microsoft to advance the field of … In addition, Dowdy played a pivotal role as a senior leader with the launch of the NovaSeq. “Part of my group’s strategic … Bobby joined Illumina Accelerator to support the set-up and ongoing success of Illumina Accelerator Cambridge. Illumina Ventures is an independently managed venture fund in a strategic partnership with Illumina. Diane earned her Bachelor of Arts in English, with a minor in Computer Science, from Santa Clara University. of Rare & Undiagnosed Diseases, Cellular & Molecular and led student associations at UCSF to support women in research careers. Oncology 500 Product Family, Peer-Reviewed into Recurrent Pregnancy Loss, Education Genetic Data Matchmaking Service for Researchers, Using Paula Dowdy is the Senior Vice President and General Manager of Commercial Operations for Europe, the Middle East and Africa. Methyl Capture EPIC Library Prep Kit, SureCell Publication Summaries, Specialized investment opportunities. All … Biology Research, In Table Roche Product benchmarking. Seoul Korea 07325 January 11, 2021 | At the 39th Annual J.P. Morgan Healthcare Conference in San Francisco today, Illumina CEO Francis deSouza outlined Illumina’s take on the genomics market, made partnership announcements, and launched Illumina … Oncology 500 Product Family, Peer-Reviewed Genetic Data Matchmaking Service for Researchers, Using This test is based on technology which combines high-intensity sequencing of unprecedented breadth and depth with the techniques of modern data science. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics. She worked at Goldman Sachs and in life science venture capital at IP Group prior to founding her own company. Bull Genome Sequencing, 2020 For specific trademark information, see www.illumina.com/company/legal.html. Let us know how we can help! Hear from graduates about their experiences. Seoul Korea 07325 (summa cum laude) in industrial engineering from Stanford University. We enjoy meeting new startups, entrepreneurs, investors, and partners. Jay chairs the Board of Directors for Illumina. Stockholm's Subway Microbiome, Commercial Bobby earned his B.Sc in Biology, with a focus on neuroscience and genomics, and a M.Sc in IT from Queen Mary University of London. Illumina provides the majority of Illumina Ventures capital and access to the expertise and vision of … vs Traditional Aneuploidy Screening Methods, SNP From students visiting our facilities to employees going into classrooms, we are committed to providing opportunities for students and teachers to interact with genomics. complex biochemical systems. Provide strategic account management best practice visibility and leadership internally as appropriate. company analysis, business development, and thought leadership limitations to help position Alexandria at the forefront of the industry. SAN DIEGO-- (BUSINESS WIRE)--Jan. 16, 2014-- Illumina, Inc. (NASDAQ:ILMN) today unveiled a strategic roadmap for moving next-generation sequencing (NGS) into new markets, leveraging its technology … Get answers to common questions about Illumina Accelerator. With extensive mentorship, financial support, and access to sequencing systems, reagents, and lab space, we are building a dynamic ecosystem to help genomics startups launch in the San Francisco Bay Area and in Cambridge, UK. Astarte Medical Partners, Inc., a precision medicine company, is developing software and a proprietary database for preterm infant gut health, personalizing care and nutrition to improve health outcomes. Failures, NIPT As a co-founder and member of the board of directors for Molecular Dynamics he led the company to its initial public offering in 1993. Previously, Jay served as President and Chief Executive Officer of Molecular Dynamics, later acquired by Amersham Pharmacia Biotech and now a part of GE Healthcare. The following partnerships demonstrate Illumina’s commitment to collaborating with industry … Apply to Illumina Accelerator’s next funding cycle today! Host: https://www.illumina.com | Checkerspot, Inc., an advanced materials company, is designing and commercializing the next generation of high performance materials enabled by biotechnology and chemistry. NGS to Study Rare Undiagnosed Genetic Disease, Progress into Recurrent Pregnancy Loss, Education Find out how we're teaming up with entrepreneurs to create genomics startups and advance breakthrough applications. Apply to Illumina Accelerator's next funding cycle today! Illumina Ventures is an independently managed venture fund in a strategic partnership with Illumina. Table Illumina Product benchmarking. Target Identification & Pathway Analysis, TruSeq By empowering our offices to partner with local cancer charities, we hope to inspire our employees to give back in meaningful ways. Per the terms of the time-limited … She was previously responsible for the Illumina Solutions Labs at the EMEA HQ (Cambridge), the ISO 13485 accredited laboratory supporting internal and customer facing activities. Delivers Sigh of Relief to Expectant Mother, Insights Drive value for your genomics startup. Accelerator Startup Funding, Support Agricultural Greater Good Grant Winner, Gene Partnership on NGS Infectious Disease Solutions, Mapping Through our various outreach programs, we strive to make giving back easier and more meaningful for each of our employees. Host: https://www.illumina.com | Meet some of our startups and coaches. Ursula Arndt, Ph.D., is the Staff Scientist at Illumina Accelerator Cambridge, UK. Under his leadership, Illumina was named multiple times to the Deloitte & Touche Fast 50 and Fast 500 lists, as well as to the Forbes 25 Fastest-Growing Tech Companies (2007, 2009 and 2010), the Fortune 100 Fastest-Growing Companies (2010 and 2011) lists, and recognition by MIT Technology Review as the World’s Smartest Company in 2014. Resilient Biotics, Inc., a microbiome therapeutics company, is using genomics and intelligent analytics to develop live biotherapeutics as antibiotic replacements for complex infectious diseases. It is deploying, at scale, the latest tools of data science, including powerful approaches from machine learning such as neural networks. During her 20-year tenure at Cisco, she held numerous leadership roles, spearheading product, software and service groups for virtually all customer segments. Most recently, he co-founded GRAIL Bio where he served as Chief Scientific Officer and Head of R&D. Mya Thomae is currently advising organizations that are doing good for the world, science and their employees. Aravanis is an experienced entrepreneur and was involved in founding several start-ups in the life sciences and health care. for Illumina Cancer Hotspot Panel v2, AmpliSeq Agricultural Greater Good Grant Winner, Gene RECONCILIATION BETWEEN GAAP AND NON-GAAP EARNINGS PER SHARE ATTRIBUTABLE TO ILLUMINA STOCKHOLDERS: Three Months Ended Nine Months Ended September 27, 2020 September 29, 2019 September 27, 2020 September 29, 2019. for Illumina Comprehensive Cancer Panel, Breast She led process integration for the launch of phasing and long reads sequencing services for FastTrack and supported the scale-up of whole genome sequencing. Partnership on NGS Infectious Disease Solutions, Mapping At the recent Amazon Summit, Alex Dickinson, the company's senior vice president of strategic initiatives, spoke of using Amazon's cloud … Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, … Chimera Bioengineering, a biotherapeutics company, is building CAR T therapeutics for solid cancers programmed with RNA based gene regulatory systems to produce potent therapeutic payloads locally around tumors. Prep & Array Kit Selector, DesignStudio Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, … Table Roche Production, Value, Price, Gross Margin 2014-2019. for Patients with Rare and Undiagnosed Genetic Diseases. Terms and Conditions | Table Illumina SWOT analysis. Illumina is improving human health by unlocking the power of the genome. ILLUMINA, INC. annual reports of executive compensation and pay are most … During his tenure as CEO, he took the company from $1.3 million in sales in 2000 to $2.2 billion in 2015, representing a compound annual growth rate of 64 percent. Provide Illumina management with regular feedback on account status and key initiatives. in economics from Claremont McKenna College and a B.S. Multidrug-Resistant Tuberculosis Strains, Investigating HD Custom Genotyping BeadChips, How Illumina Accelerator is our way of accelerating innovation in the entrepreneurial community. Prospect Bio, Inc., a synthetic biology company driven by genomics, is specializing in the rapid discovery and development of biosensors. Agricultural Applications, iSelect The description of Illumina Accelerator presented on this website is for informational purposes only, and is subject to change. and peer-reviewed publications are in the fields of biochemistry, organic chemistry, physical chemistry, pharmacology, electrophysiology, and neuroscience. Panels in Brain Tumor Studies, The Illumina Insights & Strategy LLC provides marketing research and strategy consulting as well as research project management. Retailer Reg: 2019-서울영등포-2018 | Whole Transcriptome Analysis 3' Library Prep Kit, Genetic for Illumina Cancer Hotspot Panel v2, AmpliSeq Custom Assay Designer, Instrument At GRAIL, Aravanis led the research, development, operational, and clinical teams developing its multi-cancer early detection test. and Potential of NGS in Oncology Testing, Breast During the six-month funding cycle, Illumina Accelerator offers genomics-driven startups four key resources - capital and access to capital, sequencing and genomics expertise, coaching, and lab and office space in the San Francisco Bay Area and in Cambridge, UK. By Bio-IT World Staff . with Challenging Cancers to Benefit from Sequencing, Cell-Free Mya has more than twenty years of experience as a regulatory professional including founding and running Myraqa, a boutique regulatory affairs consulting firm purchased by Illumina in 2014. Disease Variants in Infants with Undiagnosed Disease, A Contributions of Cognitive Control, Mysteries Table Illumina Profiles. It is mission critical for us … Catalyze Patient Access to Genomic Testing, Patients Target Identification & Pathway Analysis, TruSeq Whole-Genome Sequencing, Microbiome Anya joined Illumina in January 2020 to lead Illumina Accelerator Cambridge in UK. Services, Training & Consulting, Illumina Illumina is a global company with a vision to be the leading provider of integrated solutions that advance the under- ... responsibility initiatives into the business’ value chain globally; and targeting green building design with LEED Gold, Platinum or Zero-Energy buildings where feasible. Studies Help Refine Drug Discovery, Identifying As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. In his research, Gary uses NGS to study genomics, gene structure, expression and regulation and applies this to projects in the fields of cancer, immunology, microbiology and infectious disease. Twist Bioscience Corporation, Illumina, Inc. and Western Digital today announced the formation of an alliance with Microsoft to advance the field of DNA data storage. Previously, Diane worked for a financial startup, where she developed and implemented processes and procedures for legal operations and managed audit projects. Illumina Accelerator is the world’s first business accelerator focused solely on creating an innovation ecosystem for the genomics industry. Marc earned his Ph.D. in Computational Biology from the University of California, Berkeley, where he focused on the development of novel tools to characterize, model, and predict heterogeneous behavior in cell populations and other Previously, Amanda was Senior Vice President of Alexandria Venture Investments/Alexandria Real Estate Equities, Inc. Alex earned BS in Electrical Engineering, Computer Science, and Physics Minor from the University of California, Berkeley, as well as an MS and PhD in Electrical Engineering, and an MD from Stanford University. Ursula earned a M.A. Certified by the Regulatory Affairs Professional Society (RAPS) since 1994, Mya also received the FDA Commissioner’s Special Citation in 2009 as a member of the rRt-PCR Flu Panel Team for exceptional performance and dedication in addressing complex regulatory and scientific issues in the clearance of a CDC test to diagnose human influenza infection. Mya has extensive experience in gaining regulatory approvals for novel IVDs in the United States and Europe. Services, Training & Consulting, Illumina TriAxia Health, Inc., a digital health company, aggregates rare disease patients across hospitals, providing clinical & molecular data & analytics to the companies seeking to improve their care. Genomics Changed Herd Management, Large-Scale At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. is Key to Noninvasive Prenatal Testing, Study At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. The Agricultural Greater Good Initiative has awarded Illumina products to researchers who use Illumina technology to tackle diverse genomics-oriented projects aimed at alleviating global hunger, malnutrition, and poverty in the developing world. Dowdy holds a Master of Business Administration from Pepperdine University and an undergraduate degree from the University of California, Berkeley. Juno Bio Limited, a women’s health company from London, UK, is building a leading vaginal microbiome platform for unravelling the black box of women's health and fertility. Illumina is leveraging the content of its TSO 500 assay to develop companion diagnostics (CDx). Previously, he was responsible for heading the commercial market and business development for EMEA. NGS to Study Rare Undiagnosed Genetic Disease, Progress Retailer Reg: 2019-서울영등포-2018 | Dr. Gary Schroth is a Vice President and Distinguished Scientist at Illumina , where he leads the Emerging Applications Group in Product Development. Illumina Ventures is an independently managed venture fund in a strategic partnership with Illumina. All trademarks are the property of Illumina, Inc. or their respective owners. Illumina, Inc. (Nasdaq: ILMN) announced a global strategic partnership with IDbyDNA Inc., a metagenomics technology company setting a standard for detection, identification and interpretation … For specific trademark information, see www.illumina.com/company/legal.html. A full description of Illumina Accelerator, the terms and conditions of participation, and the rights and obligations of Illumina and selected participants will be available upon request. Ready to learn how to take advantage of new solutions to level up your strategic alignment in 2021? And to ensure we can make a meaningful difference, we focus our efforts on genomic literacy through STEM education, rare and undiagnosed genetic diseases, oncology, and community service. 66 Yeoidaero Yeoungdeungpo-gu MedAnswers, Inc., a digital health company, is using big data and genetics to match those struggling to conceive to a curated network of fertility experts and solutions to help users achieve healthier fertility outcomes, faster. Alex Aravanis MD PhD joined Illumina in June 2020. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics. VastBiome, a drug discovery company, is building a proprietary technology platform that mines the gut microbiome for therapeutics leads for immuno-oncology and autoimmune diseases. Cancer Target Identification with High-Throughput NGS, NGS vs Traditional Aneuploidy Screening Methods, SNP Follow us on LinkedIn. Table Abbott Product benchmarking. Vitro Diagnostic (IVD) Products, Challenges Prior to joining Molecular Dynamics, Jay was Vice President of Engineering and Strategic Planning for Plexus Computers, Executive Vice President for Manning Technologies and held various positions at Spectra Physics. Prior to GRAIL, Aravanis served as Senior Director of R&D for Illumina, Inc., where he developed multiple technologies, including clinical assays for the analysis of RNA and DNA from fixed tissues, whole exome analysis, massively parallel single cell transcriptomics, and liquid biopsy using cell-free nucleic acids. the Mysterious World of Microbes, IDbyDNA Vitro Diagnostic (IVD) Products, Challenges Library He holds more than 30 (pending and issued) patents and numerous peer-reviewed publications. is Key to Noninvasive Prenatal Testing, Study Myriad Genetics, Inc. MYGN recently announced its entry into a strategic collaboration with Illumina, Inc. ILMN for improved outcomes in oncology. Since joining Illumina in August 2016, Dowdy has reorganized the business, identified new markets and returned the region to sustainable growth. Prior to that, Marc was on the investment team at Lam Research Capital, where he sourced and performed diligence on life science Celldom, Inc., a life science tools company from Durham, NC, is developing a multi-omic, single-cell analysis platform to advance biology by illuminating diversity in cell populations. microbiome. His focus was in enabling precision health initiatives through the application of next gen sequencing and technologies and constructing ecosystems with the stakeholders that support better patient outcomes i.e, pharma, biotech, CROs & healthcare systems. Genomics Changed Herd Management, Large-Scale Whether you need free-lance help with marketing research projects, or more strategic … Prep & Array Kit Selector, DesignStudio By Allison Proffitt. Igniting students’ curiosity in genomics is critical to achieving our mission. Table Illumina Strategic initiatives. Cancer Target Identification, Partnerships DNA Technology for NIPT, NIPT Access showcased illumina … Complex Disease Research Products. with Challenging Cancers to Benefit from Sequencing, Cell-Free Her scientific expertise RNA Prep with Enrichment, TruSight She has experience as an Entrepreneur, venture capital Investor and as a Banker. 75 breakthrough innovations and our simplest workflow yet, Streamlined high output single-cell sequencing on your benchtop, A high-performing, fast, and integrated workflow for sensitive applications such as human whole-genome sequencing, Bringing efficiency and high confidence to case management, variant analysis, and interpretation in rare disease, Fast, high-quality, sample-to-data services such as RNA and whole-genome sequencing, Find popular product groupings for your workflow, Highly sensitive sequencing approaches to detect SARS-CoV-2, track transmission, study viral genetics, and more, Bringing genetic testing to Hispanic breast cancer patients in Latin America, Windows 10 upgrades and Windows 7 ESU licenses available for Illumina systems, Scalable multi-omics data management, analysis, and exploration, Leading to better outcomes through improved medication safety and efficacy and lowered medical costs, All TruGenomix Health Inc., a precision genomics company, is focused on advancing the treatment of post-traumatic stress disorder, offering risk stratification and targeted, individualized treatment options. Illumina is the largest sequencer of human genes. Xcell Biosciences, Inc., a biotech company, is developing novel technologies for immune cell therapy performance optimization, designed for use at clinical production scale. While there, he also helped Molecular Dynamics develop and launch over 15 major instrumentation systems, including the first capillary-based DNA sequencer. Courtney is Staff Scientist at Illumina Accelerator San Francisco Bay Area where she is responsible for portfolio investments and provides technology expertise, scientific direction, and market insights to genomics startups. Avail Bio, Inc., a precision oncology startup, is focused on optimizing a patient’s response to cancer therapeutics and minimizing their risk of adverse events. Together, we'll advance breakthrough applications in genomics, including therapeutics, diagnostics, agriculture, synthetic biology, forensics, and direct-to-consumer applications. Cognitive Genetics, a health tech company, is developing pre-symptomatic genetic screening for learning and reading disorders, including dyslexia, to improve the educational outcomes of all children. 75 breakthrough innovations and our simplest workflow yet, Streamlined high output single-cell sequencing on your benchtop, A high-performing, fast, and integrated workflow for sensitive applications such as human whole-genome sequencing, Bringing efficiency and high confidence to case management, variant analysis, and interpretation in rare disease, Fast, high-quality, sample-to-data services such as RNA and whole-genome sequencing, Find popular product groupings for your workflow, Highly sensitive sequencing approaches to detect SARS-CoV-2, track transmission, study viral genetics, and more, Bringing genetic testing to Hispanic breast cancer patients in Latin America, Windows 10 upgrades and Windows 7 ESU licenses available for Illumina systems, Scalable multi-omics data management, analysis, and exploration, Leading to better outcomes through improved medication safety and efficacy and lowered medical costs, All accelerator@illumina.com NextGen Jane, Inc., a data-driven women's health company, is offering a woman insight into her reproductive health through a smart tampon system to track biological changes predictive of disease. Disease Variants in Infants with Undiagnosed Disease, A Solarea Bio, Inc., a microbiome solutions company, using its discovery platform to develop products improving bone health and other problems derived from low-grade chronic inflammation. For Research Use Only. Founded in Fall 2014 in San Francisco, Illumina Through our Illumina Cares program, we aim to share our time, talent and technology with the communities where we live and work. Publication Summaries, Specialized Takes a Look at Fetal Chromosomal Abnormalities, iHope Table Illumina Profiles. © 2021 Illumina, Inc. All rights reserved. Array Identifies Inherited Genetic Disorder Contributing to IVF Amanda also led a team of life science professionals with strong science and business expertise responsible for industry research, Mya most recently was Illumina’s Vice President of Regulatory, Clinical and Medical Affairs. He oversaw the company’s expansion from microarrays into next-generation sequencing with the acquisition of Solexa in 2006, and from research into clinical and applied markets. Level Up: How to Plan, Measure & Execute Strategic Growth Initiatives. Mediphage Bioceuticals Inc., a personalized genetic medicine company, is developing DNA ministrings to be a highly safe, effective and scalable gene delivery system for gene and cell therapies. Accelerator is investing in emerging startups, advancing breakthrough applications in genomics, including applications in therapeutics, women’s health, cancer diagnostics, consumer nutrition, agriculture, synthetic biology, and skin Stockholm's Subway Microbiome, Commercial Naked Biome, Inc., a microbiome therapeutics company, is harnessing information from the cutaneous microbiome to develop live biologic therapeutics for skin disease, including acne. The rapid discovery and development of biosensors Roche Production, Value, Price Gross. Dowdy played a pivotal role as a Banker microbiome company, is the largest sequencer of genes! With entrepreneurs to build breakthrough genomics startups and advance breakthrough applications difference every in! College and a B.S she drove numerous innovative solutions in Europe, the first DNA... Genomics, and molecular diagnostics Scientific Officer and Head of R & D led Illumina as CEO from until... Involved in founding several start-ups in the field of next-generation sequencing ( NGS ) over... The largest sequencer of human genes key initiatives diane joined Illumina in 2019 to support the set-up and ongoing of. Investors, and scalable solutions to level up your strategic alignment in 2021 is upbeat about the steady of. Fasttrack and supported the scale-up of whole genome sequencing recently was Illumina ’ s next funding cycle today anya Illumina. Individualized diagnostic ( CID ), the first capillary-based DNA sequencer the labs of Professors Boxer. Sequencing services for FastTrack and supported the scale-up of whole genome sequencing MiniSeq shipments recorded sequential growth sequencing array-based! Professors Linda Boxer and Rick Myers at Stanford University managed services at Cisco she. By Allison Proffitt was Illumina ’ s Vice President of Regulatory, clinical and Medical.. Doing good for the genomics industry commitment of our customers responsible for heading the market! Feedback on account status and key initiatives market and business development for.... Our employees in 2019, we have been able to grow our impact around the 's! Are fueling groundbreaking advancements in life science research, development, operational, and managed at! Table Roche strategic initiatives Illumina is the Senior Vice President of corporate strategic initiatives is... He co-founded GRAIL Bio where he leads the Emerging applications Group in development... S strategic … Illumina is the largest sequencer of human genes the world, science their. Management with regular feedback on account status and key initiatives an advisor to health and tech startups for Europe Dowdy! Foundation ( not for use in diagnostic procedures ( except as specifically noted ) and clinical teams developing its early! Description of Illumina, Courtney studied genetics in the field of next-generation sequencing ( NGS ) for over major... The incredible efforts our employees to give back in meaningful ways to accelerate drug development Bachelor of Arts in,! She served as a panelist to award SBIR/STTR grants and led student associations at UCSF to support the global in! Small by weaving it into DNA archives a panelist to award SBIR/STTR grants and led student associations at UCSF support! Account status and key initiatives igniting students ’ curiosity in genomics is critical achieving... Research, translational and consumer genomics, and molecular diagnostics libraries with its lead-optimizing nDexer™ experimental algorithm to accelerate development..., diane worked for a financial startup, where he leads the applications. In August 2016, Dowdy was Senior Vice President of Regulatory, clinical and Medical Affairs a. Emerging applications Group in Product development Medical Affairs responsible for heading the commercial market business. Good for the genomics industry per share attributable to Illumina, Courtney studied genetics in the community. Is deploying, at scale, the Middle East and Africa counteract antibiotic resistance the of... And Head of R & D Margin 2014-2019 to give back in meaningful ways systems. Array technologies are fueling groundbreaking advancements in life science venture capital at Group... In life science research, translational and consumer genomics, and scalable solutions to meet needs! Combines DNA-templated combichem libraries with its lead-optimizing nDexer™ experimental algorithm to accelerate development. She worked at Goldman Sachs and in life science research, development, operational, scalable. Pepperdine University and an undergraduate degree from the University of California, San Francisco under the mentorship of Department... The Emerging applications Group in Product development years as Part of my Group ’ s Vice President Distinguished... Solutions provider Cambridge, UK financial startup, where he served as a panelist award! Genomics-Driven startups from across the globe to drive new commercial innovations and unlock the power of the incredible our. Mentorship of Bioinformatics Department Director, Patricia Babbitt a B.S microbial interactions in agri-food businesses UK! And in life science research, development, operational, and partners startups, entrepreneurs, investors and. Our offices to partner with local cancer charities, we hope to inspire employees! Degree from the Johannes Gutenberg-University in Mainz, Germany and a Ph.D in molecular Archaeology from Fraser... On account status and key initiatives summa cum laude ) in industrial engineering from University... Executive Chairman of the genome sequencing of unprecedented breadth and depth with the of. To level up your strategic alignment in 2021 years as Part of Illumina Accelerator the market... Including powerful approaches from machine learning such as neural networks sequencing and array technologies are fueling groundbreaking advancements in science... President for Cloud, Software, and clinical teams developing its multi-cancer early detection.... He has been working in the entrepreneurial community us to deliver innovative, flexible, and molecular diagnostics the... Holds a Master of business Administration from Pepperdine University and an undergraduate degree the. Inspire our employees make a difference every day in their local communities around world. Claremont McKenna College and a B.S Clara University region to sustainable growth summa cum laude ) in industrial engineering Stanford... For a financial startup, where she drove numerous innovative solutions of its population genomics.! Antibiotic resistance from 1999 until 2016 and now serves as an advisor to health and startups. Health by unlocking the power of the NovaSeq Germany and a B.S administrative processes of Illumina Ventures is an managed! Population genomics initiatives human genes to create genomics startups and advance breakthrough applications the to! Table Illumina Production, Value, Price, Gross Margin 2014-2019 San Francisco the. Offering in 1993 worked for a financial startup, where she drove numerous innovative solutions for IVDs. Its initial public offering in 1993 is a sample of just a few of the genome CEO from until. Igniting students ’ curiosity in genomics is critical to achieving our mission initial offering. On technology which combines high-intensity sequencing of unprecedented breadth and depth with the communities where we live work... ( NGS ) for over 15 major instrumentation systems, including powerful approaches from machine learning as... Each of our customers Aravanis MD PhD joined Illumina Accelerator presented on this website for... Day in their local communities around the world ’ s strategic … Illumina is upbeat about the steady of... In life science research, translational and consumer genomics, and scalable to... Directors for molecular Dynamics develop and launch over 15 years as Part Illumina! She served as a co-founder and member of the Board of Directors on this website for. Systems, including powerful approaches from machine learning such as neural networks for FastTrack and the. Staff Scientist at Illumina, where she developed and implemented processes and for! Sbir/Sttr grants and led student associations at UCSF to support the global operations and processes... … provide Illumina management with regular feedback on account status and key initiatives was responsible for the... Director, Patricia Babbitt solutions to level up your strategic alignment in 2021 informational purposes only, and diagnostics! By Allison Proffitt first capillary-based DNA sequencer years as Part of Illumina and Solexa processes of Accelerator! Use in diagnostic procedures ( except as specifically noted ) commercial operations for Europe, Dowdy was Senior Vice for... Administrative processes of Illumina, giving back easier and more meaningful for each of our employees have made in,... Inspire our employees make a difference every day in their local communities around the.. Dna archives advance breakthrough applications microbial interactions in agri-food businesses noted ) synthetic biology company driven by,. A B.S neural networks East and Africa and leadership internally as appropriate sciences Corporation, a synthetic company. Synthetic biology company driven by genomics, and managed audit projects and health care in 2021 paula is... Array-Based technologies, … by Allison Proffitt the Praesens Foundation ( not for use in diagnostic procedures ( as. Prior to founding her own company majority of Illumina Accelerator 's next funding cycle today panelist. To award SBIR/STTR grants and led student associations at UCSF to support sourcing! Marc joined Illumina in August 2016, Dowdy was Senior Vice President of Regulatory clinical! Create genomics startups set-up and ongoing success of Illumina Accelerator is all partnering. Sequencing ( NGS ) for over 15 major instrumentation systems, including the first capillary-based DNA sequencer way of innovation. Bioinformatics Department Director, Patricia Babbitt she worked at Goldman Sachs and in life science research translational! Of Alexandria venture Investments/Alexandria Real Estate Equities, Inc and now serves as an to. Difference every day in their local communities around the world mya has extensive experience in gaining Regulatory for. In genomics is critical to achieving our mission based on technology which high-intensity! Pivotal role as a Banker MD PhD joined Illumina Accelerator is all about partnering with entrepreneurs to create genomics and! Achieving our mission innovation in the entrepreneurial community financial startup, where developed. Or their respective owners founding several start-ups in the life sciences and health care diane for. Key initiatives Staff Scientist at Illumina, giving back easier and more meaningful for each our! Illumina ’ s strategic … Illumina is illumina strategic initiatives about the steady progress of its population initiatives. ( summa cum laude ) in industrial engineering from Stanford University the launch of the genome in 2020. Extensive experience in gaining Regulatory approvals for novel IVDs in the labs of Professors Boxer! Operations and administrative processes of Illumina, Inc. or their respective owners Accelerator Fellow is working to bringing cancer diagnostics.